首页 | 本学科首页   官方微博 | 高级检索  
检索        

棕色脂肪组织与肥胖症药物治疗的新靶点
引用本文:钱杰,张玉彬.棕色脂肪组织与肥胖症药物治疗的新靶点[J].药学进展,2012,36(11):487-493.
作者姓名:钱杰  张玉彬
作者单位:中国药科大学生命科学与技术学院,江苏 南京,210009
摘    要:肥胖症与许多代谢性疾病密切相关,而目前尚无治疗肥胖症的理想药物。棕色脂肪组织作为产热器官,可分解代谢脂肪,因而成为治疗肥胖症的重要靶组织。简述棕色脂肪组织的结构及作用,详细介绍了基于棕色脂肪组织治疗肥胖的药物作用靶点,其中具有代表性的有过氧化物酶体增殖物激活受体Y辅激活因子1a、锌指蛋白PRDM16和胎盘特异性蛋白8等,并对利用这些靶点治疗肥胖症的研究进行了综述。

关 键 词:肥胖症  棕色脂肪组织  过氧化物酶体增殖物激活受体Y辅激活因子1a  PRDM16  胎盘特异性蛋白8

Brown Adipose Tissue and New Targets for Obesity Treatment
QIAN Jie , ZHANG Yu-bin.Brown Adipose Tissue and New Targets for Obesity Treatment[J].Progress in Pharmaceutical Sciences,2012,36(11):487-493.
Authors:QIAN Jie  ZHANG Yu-bin
Institution:(School of Life Science and Technology,China Pharmaceutical University,Nanjing 210009,China)
Abstract:Obesity is a disease closely related to many metabolic diseases. Up to now, however, there is still no ideal drug for the treatment of obesity. Brown adipose tissue (BAT), as a key thermogenic organ through the catabolism of triacylglyeerine, has become an important target for the treatment of obesity. In this article, features of BAT and its function are briefly described. Drug targets which are based on BAT for obesity treatment such as peroxisome proliferator-aetivated receptor gamma coactivator-la(PGC-1a), zinc-finger protein PRDM16, and placenta specific 8 (Plac8) are introduced in detail. And the research on the treatment of obesity with these targets is also reviewed.
Keywords:obesity  brown adipose tissue  PGC-1a  PRDM16  Plac8
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号